Cargando…
REASSURED Multiplex Diagnostics: A Critical Review and Forecast
The diagnosis of infectious diseases is ineffective when the diagnostic test does not meet one or more of the necessary standards of affordability, accessibility, and accuracy. The World Health Organization further clarifies these standards with a set of criteria that has the acronym ASSURED (Afford...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869588/ https://www.ncbi.nlm.nih.gov/pubmed/35200384 http://dx.doi.org/10.3390/bios12020124 |
_version_ | 1784656533883191296 |
---|---|
author | Otoo, Jonas A. Schlappi, Travis S. |
author_facet | Otoo, Jonas A. Schlappi, Travis S. |
author_sort | Otoo, Jonas A. |
collection | PubMed |
description | The diagnosis of infectious diseases is ineffective when the diagnostic test does not meet one or more of the necessary standards of affordability, accessibility, and accuracy. The World Health Organization further clarifies these standards with a set of criteria that has the acronym ASSURED (Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free and Deliverable to end-users). The advancement of the digital age has led to a revision of the ASSURED criteria to REASSURED: Real-time connectivity, Ease of specimen collection, Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free or simple, and Deliverable to end-users. Many diagnostic tests have been developed that aim to satisfy the REASSURED criteria; however, most of them only detect a single target. With the progression of syndromic infections, coinfections and the current antimicrobial resistance challenges, the need for multiplexed diagnostics is now more important than ever. This review summarizes current diagnostic technologies for multiplexed detection and forecasts which methods have promise for detecting multiple targets and meeting all REASSURED criteria. |
format | Online Article Text |
id | pubmed-8869588 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88695882022-02-25 REASSURED Multiplex Diagnostics: A Critical Review and Forecast Otoo, Jonas A. Schlappi, Travis S. Biosensors (Basel) Review The diagnosis of infectious diseases is ineffective when the diagnostic test does not meet one or more of the necessary standards of affordability, accessibility, and accuracy. The World Health Organization further clarifies these standards with a set of criteria that has the acronym ASSURED (Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free and Deliverable to end-users). The advancement of the digital age has led to a revision of the ASSURED criteria to REASSURED: Real-time connectivity, Ease of specimen collection, Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free or simple, and Deliverable to end-users. Many diagnostic tests have been developed that aim to satisfy the REASSURED criteria; however, most of them only detect a single target. With the progression of syndromic infections, coinfections and the current antimicrobial resistance challenges, the need for multiplexed diagnostics is now more important than ever. This review summarizes current diagnostic technologies for multiplexed detection and forecasts which methods have promise for detecting multiple targets and meeting all REASSURED criteria. MDPI 2022-02-16 /pmc/articles/PMC8869588/ /pubmed/35200384 http://dx.doi.org/10.3390/bios12020124 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Otoo, Jonas A. Schlappi, Travis S. REASSURED Multiplex Diagnostics: A Critical Review and Forecast |
title | REASSURED Multiplex Diagnostics: A Critical Review and Forecast |
title_full | REASSURED Multiplex Diagnostics: A Critical Review and Forecast |
title_fullStr | REASSURED Multiplex Diagnostics: A Critical Review and Forecast |
title_full_unstemmed | REASSURED Multiplex Diagnostics: A Critical Review and Forecast |
title_short | REASSURED Multiplex Diagnostics: A Critical Review and Forecast |
title_sort | reassured multiplex diagnostics: a critical review and forecast |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869588/ https://www.ncbi.nlm.nih.gov/pubmed/35200384 http://dx.doi.org/10.3390/bios12020124 |
work_keys_str_mv | AT otoojonasa reassuredmultiplexdiagnosticsacriticalreviewandforecast AT schlappitraviss reassuredmultiplexdiagnosticsacriticalreviewandforecast |